Diagnosing the Risk of ADC Resistance Over Time, Focusing the Evolution of the Target in Response to Specific Payloads
Time: 12:15 pm
day: Conference Day Two
Details:
- Exploring the possibility of ADC target sub-clones expressing at the target cell in a response to specific ADC therapeutics
- Diving into whether specific ADC designs lend themselves to target resistance which should be considered when deciding dosing schedules
- Confirming whether resistance risk is a property which can be quantified in the target selection process